MGNX Receives $24.5M Milestone
MacroGenics to receive $24.5M milestone from Sanofi following FDA approval of TZIELD expansion in type 1 diabetes
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.